Epizyme Inc.

NASDAQ: EPZM · Real-Time Price · USD
1.47
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Epizyme Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
37.43M
Cost of Revenue
10.5M
Gross Profit
26.93M
Operating Income
-226.94M
Interest Income
n/a
Pretax Income
-251.1M
Net Income
-251.12M
Selling & General & Admin
133.96M
Research & Development
130.97M
Other Expenses
n/a
Operating Expenses
264.92M
Interest Expense
24.16M
Selling & Marketing Expenses
n/a
Cost & Expenses
275.42M
Income Tax Expense
22K
Shares Outstanding (Basic)
100.96M
Shares Outstanding (Diluted)
100.96M
EPS (Basic)
-2.49
EPS (Diluted)
-2.49
EBITDA
-221.69M
EBIT
-215.88M
Depreciation & Amortization
5.25M